macromolecular carrier-linked carbon monoxide releasing molecules (Alfama)

N/A

Report date: 2025/06/11 10:36:11
NME

Base Information

Drug Namemacromolecular carrier-linked carbon monoxide releasing molecules (Alfama)
Drug Alias Namecarbon monoxide-releasing molecules (Alfama)macromolecular carrier-linked CORMs (Alfama)ALF-421CORM-A1
ClassificationSmall molecules
Mechanisms of ActionTumor necrosis factor inhibitors
TargetsTumor necrosis factor
Therapy Area/IndicationsInflammationLiver Failure, AcuteMetabolic Dysfunction-Associated Steatotic Liver Disease +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPortugal
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlfama Lda
China Registration ClassN/A

Develop Information

Active CompaniesProterris
Inactive CompaniesAlfama Lda
Active IndicationsLiver Failure, AcuteMetabolic Dysfunction-Associated Steatotic Liver DiseaseNeoplasms
Inactive IndicationsInflammationIleus

Other Information

ATC CodeN/A
Related LinksN/A